|
LATS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.188200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.023400E-01 |
| Normal-vs-Stage2 |
4.307500E-02 |
| Normal-vs-Stage3 |
1.396690E-03 |
| Normal-vs-Stage4 |
2.48269999999495E-05 |
| Stage1-vs-Stage2 |
4.012300E-02 |
| Stage1-vs-Stage3 |
9.380700E-04 |
| Stage1-vs-Stage4 |
2.5361000000057E-06 |
| Stage2-vs-Stage3 |
7.348200E-01 |
| Stage2-vs-Stage4 |
1.696380E-01 |
| Stage3-vs-Stage4 |
1.806800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.557960E-02 |
| Normal-vs-AfricanAmerican |
2.381800E-01 |
| Normal-vs-Asian |
3.849200E-01 |
| Caucasian-vs-AfricanAmerican |
9.158200E-01 |
| Caucasian-vs-Asian |
4.011900E-02 |
| AfricanAmerican-vs-Asian |
1.367030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.036700E-03 |
| Normal-vs-Female |
3.138800E-01 |
| Male-vs-Female |
7.610300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.242000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.456200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.300900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.246200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.463200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.599000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.426000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.864300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.442200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.051800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.538400E-03 |
| Normal-vs-Grade 2 |
8.586200E-01 |
| Normal-vs-Grade 3 |
2.436100E-03 |
| Normal-vs-Grade 4 |
1.6242299999969E-05 |
| Grade 1-vs-Grade 2 |
1.460120E-02 |
| Grade 1-vs-Grade 3 |
1.150270E-04 |
| Grade 1-vs-Grade 4 |
1.92524999999E-05 |
| Grade 2-vs-Grade 3 |
1.137980E-03 |
| Grade 2-vs-Grade 4 |
2.57839999995291E-06 |
| Grade 3-vs-Grade 4 |
1.151840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.039200E-01 |
| Normal-vs-ccB subtype |
5.765900E-04 |
| ccA subtype-vs-ccB subtype |
6.92299999993651E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.043300E-03 |
| Normal-vs-N1 |
1.779230E-03 |
| N0-vs-N1 |
1.298380E-01 |
|
|
